德盈控股(02250.HK)成立合營公司拓泰國市場
德盈控股(02250.HK)公佈,公司與王健志、其旗下凱登成立的合營企業B.Duck Thailand Company Limited,與各方簽訂股東協議,將成立中國附屬公司及泰國公司,以推廣集團或被授權商於泰國或其他地方的產品銷售。
根據股東協議,B.Duck Thailand註冊資本總額爲1,000萬元,其中德盈將出資650萬元,德盈並承諾提供或促使集團的被授權商向中國附屬公司提供產品,從而在泰國或德盈及凱登同意的其他地方銷售。
公司表示,王健志擁有多年物流行業經濟,料成立合營公司將有助於將業務擴張至東南亞市場。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.